Commodore Capital »

Aeglea Biotherapeutics shares owned by Commodore Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $59M 2.0M 29.41
2024-06-30 $47M 2.0M 23.51
2024-03-31 $72M 1.9M 37.93
2023-12-31 $41M 1.9M 21.52
2023-09-30 $1.4M 116k 12.25